1. Outcomes after septal myectomy in a cohort of patients with hypertrophic cardiomyopathy;Lopez-Gutierrez;Curr Probl Cardiol,2024
2. Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice;Lopes;Eur Heart J,2024
3. Demographic and regional trends of hypertrophic cardiomyopathy-related mortality in the United States, 1999 to 2019;Minhas;Circ Hear Fail,2022
4. D.J. Kumbhani, “mavacamten in adults with symptomatic obstructive HCM who are eligible for Septal reduction therapy - American college of cardiology.” Accessed: Jul. 22, 2024. [Online]. Available: https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2022/04/01/02/42/VALOR-HCM.
5. Medical treatment strategies for hypertrophic cardiomyopathy;Hutt;Am J Cardiol,2024